K. Rodvold, R. Blum, J. Fischer, H. Zokufa, J. Rotschafer et al., Vancomycin pharmacokinetics in patients with various degrees of renal function., Antimicrobial Agents and Chemotherapy, vol.32, issue.6, pp.848-852, 1988.
DOI : 10.1128/AAC.32.6.848

R. Griffith, Introduction to Vancomycin, Clinical Infectious Diseases, vol.3, issue.Supplement_2, pp.200-204, 1981.
DOI : 10.1093/clinids/3.Supplement_2.S200

B. Farber, R. Moellering, and . Jr, Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981., Antimicrobial Agents and Chemotherapy, vol.23, issue.1, pp.138-141, 1983.
DOI : 10.1128/AAC.23.1.138

D. Levine, Vancomycin: A History, Clinical Infectious Diseases, vol.57, issue.Suppl 2, pp.5-12, 2006.
DOI : 10.1086/313440

F. Oktem, M. Arslan, F. Ozguner, O. Candir, H. Yilmaz et al., In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: Protection by erdosteine, Toxicology, vol.215, issue.3, pp.227-233, 2005.
DOI : 10.1016/j.tox.2005.07.009

I. Sabler, M. Berkovitch, J. Sandbank, E. Kozer, Z. Dagan et al., Abu-Kishk I: Exposure to hyperbaric oxygen intensified vancomycin-induced nephrotoxicity in rats, PLoS One, vol.11, 2016.
DOI : 10.1371/journal.pone.0152554
URL : https://doi.org/10.1371/journal.pone.0152554

I. Celik, M. Cihangiroglu, N. Ilhan, N. Akpolat, and H. Akbulut, Protective Effects of Different Antioxidants and Amrinone on Vancomycin-Induced Nephrotoxicity, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.30, issue.5, pp.325-332, 2005.
DOI : 10.1136/jcp.54.3.176
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2005.pto_153.x/pdf

S. Verdesca, G. Fogazzi, G. Garigali, P. Messa, and M. Daudon, Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy, Clinical Chemistry and Laboratory Medicine, vol.9, issue.3, pp.515-520, 2011.
DOI : 10.1016/S0272-6386(03)00829-1

T. Lodise, N. Patel, B. Lomaestro, K. Rodvold, and G. Drusano, Relationship between Initial Vancomycin Concentration???Time Profile and Nephrotoxicity among Hospitalized Patients, Clinical Infectious Diseases, vol.49, issue.4, pp.507-514, 2009.
DOI : 10.1086/600884

S. Van-hal, D. Paterson, and T. Lodise, Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter, Antimicrobial Agents and Chemotherapy, vol.57, issue.2, pp.734-744, 2013.
DOI : 10.1128/AAC.01568-12

R. Hall, K. Hazlewood, S. Brouse, C. Giuliano, K. Haase et al., Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillintazobactam, BMC Pharmacol Toxicol Pharmacotherapy, vol.14, issue.34, pp.670-676, 2013.

M. Rybak, L. Albrecht, S. Boike, and P. Chandrasekar, Nephrotoxicity of vancomycin, alone and with an aminoglycoside, Journal of Antimicrobial Chemotherapy, vol.25, issue.4, pp.679-687, 1990.
DOI : 10.1093/jac/25.4.679

T. Lodise, B. Lomaestro, J. Graves, and G. Drusano, Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1330-1336, 2008.
DOI : 10.1128/AAC.01602-07
URL : http://aac.asm.org/content/52/4/1330.full.pdf